Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lymphoma Research Foundation Awards 24 Grants to Next Generation of Lymphoma Scientists to Advance Critical Research


News provided by

Lymphoma Research Foundation

Jun 04, 2025, 12:16 ET

Share this article

Share toX

Share this article

Share toX


Foundation Underscores Commitment to Lymphoma Research with Multi-Million Dollar Investment

NEW YORK, June 4, 2025 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation, the nation's largest nonprofit organization devoted to funding innovative lymphoma research and serving the lymphoma community, has awarded 24 new research grants in 2025. These grants, totaling $2.7 million, will support cutting-edge investigations aimed at improving lymphoma diagnosis, treatment, and patient outcomes.

Each year, the Foundation's Scientific Advisory Board (SAB) identifies and funds the most promising lymphoma research projects conducted by leading scientists and early-career investigators from top institutions across the country. The 2025 grantee class encompasses 16 medical and academic institutions, with research initiatives investigating a range of lymphoma subtypes and scientific disciplines including CAR T cell therapy, microenvironment analysis, and treatments for relapsed/refractory patients.

"By investing in the brightest minds in lymphoma research, we continue to drive progress toward better treatment options and, ultimately, a cure," said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation.

Post this

"The research funded through these grants represents the forefront of lymphoma discovery and innovation," said Ann LaCasce, MD Chair of the Foundation's Scientific Advisory Board. "These projects have the potential to transform our understanding of the disease and lead to new, more effective treatment strategies for patients."

Since lymphoma and chronic lymphocytic leukemia (CLL) are considered rare diseases, it receives disproportionately less federal and philanthropic funding for research than other types of cancer. The Foundation's grant program plays a crucial role in accelerating discoveries and fostering the next generation of lymphoma experts. Since its inception 30 years ago, the Foundation has committed more than $82 million to research grants that have led to significant advancements in lymphoma care and treatment options.

"By investing in the brightest minds in lymphoma research, we continue to drive progress toward better treatment options and, ultimately, a cure," said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. "We are honored to support these researchers whose work will bring hope to patients and families affected by lymphoma."

Clinical Career Development Award (CDA)

  • Jordan Goldstein, MD - Leland Stanford Junior University
  • Paola Ghione, MD - Memorial Sloan Kettering Cancer Center
  • Robert Stuver, MD - Memorial Sloan Kettering Cancer Center

Postdoctoral Fellowship Grant

  • Pantaleo De Simone, MD - Columbia Medical Center
  • Kazuya Fuksawa, PhD - Memorial Sloan Kettering Cancer Center (Condon Family Fellow)
  • Michelle Lee, MD, PhD - Emory University
  • Etienne Leveille, MD - Yale University
  • Tianfang Ma, PhD - Dana-Farber Cancer Institute (Health Equity Initiative)
  • Daniela Magliulo, PhD - Weill Cornell Medicine
  • Priya Lakra, PhD - MD Anderson Cancer Center (Health Equity Initiative)
  • Paurnima Patil, PhD - Memorial Sloan Kettering Cancer Center (Oliver W. Press, MD, PhD Memorial Fellow)
  • Pierre Stephan, MD, PhD - Brigham and Women's Hospital (Pfizer Fellow)
  • Maria White, PhD - The University of North Carolina

Lymphoma Scientific Research Mentoring Program
Clinical Research Scholars

  • Mengyan Di, MD, PhD - University of Washington (Runge Lymphoma Project Scholar)
  • Eduardo Edelman Saul, MD - MD Anderson Cancer Center
  • Mallorie Heneghan, MD - The University of Utah (The Kellie and Jeff Fellinge Scholar)
  • Jennifer Huang, MD, PhD - Fred Hutchinson Cancer Center (Kanti R. Rai, MD Clinical Scholar)
  • Alex Niu, MD - Roswell Park Cancer Institute (Eric A. Cohen Distinguished Scholar)
  • Evelyn Orlando, MD - Weill Cornell Medicine (Kaine Family Scholar)

Laboratory/Translational Research Scholars

  • Casey Bermack, MD, PhD - MD Anderson Cancer Center (Stephanie A. Gregory, MD, FACP Distinguished Scholar)
  • Chengfeng Bi, MD, PhD - University of Nebraska Medical Center
  • Dustin McCurry, MD - MD Anderson Cancer Center (Morton Coleman, MD Innovation Fund Scholar)
  • Alexandra Rojek, MD - The University of Chicago (The Kristie Blum, MD Scholar)
  • Herman van Besien, MD - Weill Cornell Medicine

Media Contact

Nichole Musumeci, Lymphoma Research Foundation, 2123492390, [email protected], www.lymphoma.org

Twitter

SOURCE Lymphoma Research Foundation

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.